Dr. Maureen Ross

Claim this profile
Studies Multiple Myeloma
Studies Cancer remission
1 reported clinical trial
6 drugs studied

Area of expertise

1Multiple Myeloma
Maureen Ross has run 1 trial for Multiple Myeloma. Some of their research focus areas include:
alkaline phosphatase
HLA-A
HLA-B
2Cancer Remission
Maureen Ross has run 1 trial for Cancer remission. Some of their research focus areas include:
alkaline phosphatase
HLA-A
HLA-B

More about Maureen Ross

Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Maureen Ross has experience with
  • Cyclophosphamide
  • Fludarabine Phosphate
  • Melphalan Hydrochloride
  • Mycophenolate Mofetil
  • Sirolimus
  • Total-Body Irradiation

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maureen Ross specialize in?
Maureen Ross focuses on Multiple Myeloma and Cancer remission. In particular, much of their work with Multiple Myeloma has involved alkaline phosphatase patients, or patients who are HLA-A.
Is Maureen Ross currently recruiting for clinical trials?
No, Maureen Ross is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Maureen Ross has studied deeply?
Yes, Maureen Ross has studied treatments such as Cyclophosphamide, Fludarabine Phosphate, Melphalan Hydrochloride.
What is the best way to schedule an appointment with Maureen Ross?
Apply for one of the trials that Maureen Ross is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.